PharmTech LCGC Sciex Webinar 11.10
|Articles|November 6, 2009

Indian companies to supply US API

India-based Arch Pharmalabs has entered into a strategic partnership with Orochem Technologies, to manufacture a US company?s active pharmaceutical ingredient (API) in late-stage clinical development using simulated moving bed (SMB) chromatography.

India-based Arch Pharmalabs has entered into a strategic partnership with Orochem Technologies, to manufacture a US company’s active pharmaceutical ingredient (API) in late-stage clinical development using simulated moving bed (SMB) chromatography.

Arch Pharmalabs provides small molecule process R&D and full life-cycle custom synthesis and manufacturing services, while Orochem Technologies manufactures SMB equipment and stationary chromatography phases for bioanalytical, solid-phase extraction, flash and preparative applications. The collaboration marks the first time that plant-scale SMB has been used to manufacture an API in India.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.